Nova Eye to Feature Several Presentations and Posters Related to iTrack Canaloplasty at 2024 ESCRS Annual Congress

Nova Eye Medical has announced that the company’s proprietary canaloplasty technology platform (iTrack and iTrack Advance) will be featured in numerous presentations and posters during the official scientific program of the European Society of Cataract and Refractive Surgeons (ESCRS) 42nd Congress on September 6-10, 2024 in Barcelona, Spain.

A summary of the ESCRS 2024 presentations and posters featuring iTrack and iTrack Advance is included below.

Podium presentations:

David Lubeck (USA); Robert Noecker (USA)

Endothelial Cell Density and Loss Following Ab-Interno Canaloplasty in patients with mild-moderate glaucoma as compared to severe glaucoma
Session: Cataract and glaucoma surgery: A combined approach
Date: Sunday, 08 September 2024

Time: 08:48 - 8:54 AM Room: Free paper podium 3

Norbert Körber (Germany), Simon Ondrejka (Germany)

6-Year Efficacy and Safety of iTrack Ab-interno Canaloplasty in Primary Open-Angle Glaucoma
Session: Cataract and glaucoma surgery: A combined approach
Date: Sunday, 08 September 2024

Time: 09:12 - 09:18 AM Room: Free paper podium 3

Lyle Newball (Colombia); David Lubeck (USA); Keith Barton (UK); Nathan Kerr (Australia)
Safety and Efficacy of Ab-interno Canaloplasty using the iTrack in Angle Closure Glaucoma: 12-month results
Session: Minimally Invasive Glaucoma Surgery (MIGS)
Date: Monday, 09 September 2024
Time: 4:42 - 4:48 PM
Room: Free paper podium 3

Paul J. Harasymowycz (Canada); David M. Lubeck (USA); Keith Barton (UK); Nathan M Kerr (Australia); Nir Shoham-Hazon (Canada)
Canaloplasty Effectiveness Correlated with Viscoelastic Volume Delivered Session: Minimally Invasive Glaucoma Surgery (MIGS)

Date: Monday, 09 September 2024 Time: 5:18- 5:24 PM
Room: Free paper podium 3

Keith Barton (UK); Nathan Kerr (Australia); David Lubeck (USA); Iqbal Ike K. Ahmed (Canada); Shamil Patel (USA)
Multicenter Canaloplasty Data Registry – Outcomes of Ab-Interno Canaloplasty Across Different Glaucoma Types and Severity

Session: Minimally Invasive Glaucoma Surgery (MIGS) Date: Monday, 09 September 2024
Time: 5:30 - 5:36 PM
Room: Free paper podium 3

David Lubeck, MD (USA), Karl Mercieca (Germany); Keith Barton (UK); Nathan Kerr (Australia)
24-Month Results of iTrack Global Data Registry to Support the Role of Canaloplasty for Treatment of Glaucoma

Session: Minimally Invasive Glaucoma Surgery (MIGS) Date: Monday, 09 September 2024
Time: 5:36 - 5:42 PM
Room: Free paper podium 3

Karl Mercieca (Germany); David Lubeck (USA); Keith Barton (UK); Nathan Kerr (Australia)
Canaloplasty Performed with the iTrack Microcatheter to Reduce IOP in Uncontrolled Glaucoma Eyes

Session: Minimally Invasive Glaucoma Surgery (MIGS) Date: Monday, 09 September 2024
Time: 5:42 - 5:48 PM
Room: Free paper podium 3

Ahmad Aref (USA); David Lubeck (USA), Keith Barton (UK), Nathan Kerr (Australia)

Predictive Factors for ≥20% IOP Reduction in Glaucomatous Eyes Undergoing Ab-interno Canaloplasty
Session: Minimally Invasive Glaucoma Surgery (MIGS)
Date: Monday, 09 September 2024

Time: 5:48 - 5:54 PM Room: Free paper podium 3

E-posters

James Murphy (USA)

Efficacy and Safety Profile of Ab-Interno Canaloplasty Performed With and Without GATT in Uncontrolled Glaucoma Eyes – 24 Month Outcomes

James Murphy (USA)

Efficacy of Ab-Interno Canaloplasty Performed with or without Gatt in Cases of Moderate Versus Severe Glaucoma

Simon Ondrejka (Germany)

Efficacy, and Safety of Ab-interno Canaloplasty using iTrack Advance in Primary Open-Angle Glaucoma

José Martinez de la Casa (Spain)

Medication Burden in 3+Meds Glaucoma Eyes Following Canaloplasty via an Ab-Interno Technique Combined with Phacoemulsification

Full session details can be accessed via the ESCRS program:

https://escrs-apps.m-anage.com/escrs2024/en-GB/pag

Nova Eye Medical will also provide additional peer-to-peer educational opportunities by hosting a series of interactive case study discussions during the ESCRS 2024. Surgeons from the USA, Canada, Spain and Germany will discuss their unique insights and experiences using the iTrack Advance as a minimally invasive glaucoma surgery (MIGS) treatment. All registered delegates of the ESCRS 2024 Annual Congress are invited to attend these sessions at the Nova Eye Medical exhibit, #F.05 (Hall 6). See full session details here: https://nova-eye.com/events/escrs2024/